These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2831419)

  • 21. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 22. [When and how to use angiotensin-converting enzyme inhibitors in heart failure].
    Muiesan G; Alicandri C
    Cardiologia; 1987 Nov; 32(11):1227-30. PubMed ID: 2834058
    [No Abstract]   [Full Text] [Related]  

  • 23. ACE inhibitors.
    Aust Nurses J; 1988 Aug; 18(2):27-8. PubMed ID: 2848480
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibitors: are there significant clinical differences?
    Jessup M
    J Am Coll Cardiol; 1989 May; 13(6):1248-50. PubMed ID: 2539404
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial].
    Risler T; Braun U; Klärner HG; Müller-Schauenburg W; Heitkamp HC; Brilla GG; Krämer BK; Seipel L
    Z Kardiol; 1991; 80 Suppl 2():40-3. PubMed ID: 1850942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of chronic heart failure with vasodilator agents].
    Zähringer J; Schultheiss HP
    Internist (Berl); 1986 May; 27(5):315-21. PubMed ID: 3015822
    [No Abstract]   [Full Text] [Related]  

  • 29. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting inhibitors in patients with congestive heart failure: a class effect?
    Pitt B
    Am J Cardiol; 1991 Jul; 68(1):106-8. PubMed ID: 2058542
    [No Abstract]   [Full Text] [Related]  

  • 31. [Do ACE inhibitors help prevent heart failure? Results of 3 clinical trials].
    Bindels AJ; Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1993 Jan; 137(4):173-6. PubMed ID: 8426667
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new angiotensin-converting enzyme inhibitor is imminent].
    Michel D
    Fortschr Med; 1988 Jul; 106(22):463-6. PubMed ID: 2851512
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
    Modesti PA; Vanni S; Gensini GF
    Ital Heart J Suppl; 2003 Aug; 4(8):623-34. PubMed ID: 14655458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin converting enzyme inhibitors.
    Breckenridge A
    Br Med J (Clin Res Ed); 1988 Feb; 296(6622):618-20. PubMed ID: 2832034
    [No Abstract]   [Full Text] [Related]  

  • 36. Lisinopril in the treatment of congestive heart failure.
    Giles TD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevention of heart failure--a new agenda.
    Cohn JN
    N Engl J Med; 1992 Sep; 327(10):725-7. PubMed ID: 1495526
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
    Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long- versus short-acting angiotensin-converting enzyme inhibitors.
    Ikram H; White HD
    J Am Coll Cardiol; 1990 Jan; 15(1):250-1. PubMed ID: 2153158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.